Objective:
Medical device acceptance of patients has grown considerably in recent
years. This has question the effectiveness of the current regulatory frameworks to ensure the performance,
safety, and quality of new devices. This article focuses on the methodical overview on
hip and knee joint replacement medical devices evaluating the procedure and proper analysis of
medical device regulation in three jurisdictions i.e. the United States of America (USA), EUROPE
and INDIA, exploring reforms been laid to stabilize and meet the requirements of existing systems,
and further analyse the additional actions which should be employed to fully meet this ultimate
goal.
Method:
We analysed the hip and knee joint replacement medical device regulation system
through a secondary research in United States, Europe and India in compliance with the updated
national regulatory authority’s legislative documents and requirements.
Result:
These three regulatory systems vary in their working, organization, acceptance for their
specific pre- and post-market evidence requirements, and transparency of process. The most challenging
factor remains the same for the countries which are to make sure safety and effectiveness
of devices, proper monitoring of its use and important compliance information readiness employing
quality management system towards new findings and acceptance for the users. A case study
of Johnson & Johnson ASR Implant was also studied, highlighting the major reforms required and
the reforms introduced in the United States, Europe and India. Thus, quality and safety reforms
are made to strengthen the premarket compliance requirements, enhancing the need of post-market
regulation through proper traceability and monitoring of devices by employing the functioning
medical device registry.
Conclusion:
Recent reforms address the major challenges in device regulation, highlighting the
need to create connecting points between the device identifier system and existing data collection
tools, such as electronic health records, and maintaining effective and up to date use of registries
to ensure post-market use of new and existing devices.
A207 UNDISCLOSED PAYMENTS BY PHARMACEUTICAL AND MEDICAL DEVICE MANUFACTURERS TO AUTHORS OF ENDOSCOPY GUIDELINES IN THE UNITED STATES
